Nanobiotix

Developer of nanotherapeutics designed to enhance cancer treatment via radioenhancement

placeParis, Ile De France, France calendar_todayFounded 2003 groups102 employees language nanobiotix.com

Social engagement

Social engagement: 20.7K social following, 9 posts in the last 12 months — around the industry typical range.

Investor mix

12 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital433%
Private equity325%
Bank & private debt217%
Other / undisclosed325%

Recent activity

23 Jun 2026
Event
BIOTECHFINANCES Healthtech Accelerations Summit
16 Jun 2026
Event
2026 Biotechnology Innovation Organization International Convention
2 Jun 2026
Partnership
anniversary
Coming soon